Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
tsA201 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
TPC1 |
Human thyroid gland papillary carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
SW1736 |
Human thyroid gland undifferentiated (anaplastic) carcinoma cell line | Human | other | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | V. Vella et al., Endocrine-Related Cancer, 2019, 26: 197–214, doi.org/10.1530/ERC-18-0310 | |||
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | S. Sperduti et al., Int. J. Mol. Sci., 2019, 20, 5548, doi:10.3390/ijms20225548 | Link | |
RAW 264.7 |
Mouse leukaemic monocyte/macrophage cell line | ATCC TIB-71 | Mouse | unknown | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | K. Lee et al., Food Funct., 2016, 7: 3073-3082; DOI: 10.1039/c6fo00187d | ||
Phoenix |
Retrovirus producer cell line (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | H.F. Alkan et al., bioRxiv preprint, 2020, doi.org/10.1101/2020.05.28.114629 | Link | ||
Phoenix |
Retrovirus producer cell line (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | X. Wang et al., Cell Death & Differentiation, 2021, 28: 3235–3250, doi.org/10.1038/s41418-021-00811-1 | Link | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | X. Wu et al., PNAS, Nov 2016, 113: E6965 - E6973 | ||
NIH/3T3 |
Mouse embryonic fibroblast cell line | ATCC CRL-1658 | Mouse | unknown | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. V. Maganti et al., J. Biol. Chem., 2015, 290(15): 9812-9822, DOI 10.1074/jbc.M114.616219 | Link | |
NCI H1299 |
Human lung carcinoma cell line | ATCC CRL-5803 | Human | respiratory system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. Lo et al., Oncogene, 2015, 34:1688-1697; doi:10.1038/onc.2014.103 | ||
N1E-115-1 |
Mouse neuroblastoma cell line (subclone of N1E-115) | Mouse | nervous system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | K. Lee et al., Arch. Pharm. Res., 2016, 39:83-93; DOI 10.1007/s12272-015-0687-3 | ||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. Park et al., Bioscience, Biotechnology, and Biochemistry, 2015, 79(4): 539-552; DOI: 10.1080/09168451.2014.991681 | Link | |
Mouse DRG neurons |
Mouse primary sensory neurons | Mouse | nervous system | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | D. Li et al., ACS Chem. Biol., 2015, 10: 1054−1063; DOI: 10.1021/cb5007536 | |||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | E. H. Han et al., PLoS ONE, 2012, 7(8): e44007, doi:10.1371/journal.pone.0044007 | Link | ||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | E. H. Han et al., Biochem. and Biophys. Res. Commun., 2015, 468:14-20; doi.org/10.1016/j.bbrc.2015.11.007 | |||
MEF |
Mouse embryonic fibroblasts | ATCC SCRC-1040 | Mouse | unknown | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | S. Wurster, Dissertation, 2014, Universitaet Wuerzburg | Link | |
MEF |
Mouse embryonic fibroblasts | ATCC SCRC-1040 | Mouse | unknown | unknown | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | M. Arechederra et al., J. Biol. Chem., 2015, 290(7): 4383-4397 | Link | |
MDPC-23 |
Mouse immortalized odontoblast cell line | ATCC CRL-2537 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | O. H. Jung, Seoul National Universtity | Link | |
MDPC-23 |
Mouse immortalized odontoblast cell line | ATCC CRL-2537 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | J.-C. Park et al., 2017, US 2017/0100458 A1 | Link | |
MDPC-23 |
Mouse immortalized odontoblast cell line | ATCC CRL-2537 | Mouse | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | H.-J. Oh et al., Biomaterials, 2015, 37: 208e217; doi.org/10.1016/j.biomaterials.2014.10.016 | ||
MDA-MB-436 |
Human breast cancer cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | L. J. Barlow, Dissertation, 2020, University Graduate School | Link | ||
MDA-MB-231 |
Human breast adenocarcinoma cell line | ATCC HTB-26 | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | B. von Neubeck et al., Int. J. of Cancer, 2018, 143: 2065–2075, DOI: 10.1002/ijc.31607 |